Abstract
The clinical management of cancer invariably involves diverse conventional modalities, including surgery, radiation, and chemotherapy. However, the complexity of human cancer requires some alternative management to improve the therapeutic efficacy of conventional treatment and/or the quality of life of cancer patients. Medicinal botanicals have recently gained more attention for cancer management. Numerous effective anticancer drugs have been developed from botanicals, and identifying new herbal sources to develop ideal chemoprevention remains an essential step in advancing the treatment of cancer. In this chapter, potential roles of ginseng herbs, especially American ginseng and notoginseng, in cancer chemoprevention are presented. The major pharmacologically active constituents of ginsengs are ginsenosides, which can be mainly classified into protopanaxadiol and protopanaxatriol groups. The recognized active anticancer compounds from American ginseng and notoginseng are ginsenosides Rg3, Rh2, and protopanaxadiol. The structure-activity relationship between their chemical structures and pharmacological activities is discussed. Sugar molecules within a ginsenoside have a high impact on cancer cells. Anticancer activities increase with the decrease of sugar number. In addition, various steaming temperatures and time treatments of the ginseng herbs can change their ginsenoside profiles and enhance their anticancer activities. This heat treatment process may increase the role and efficacy of American ginseng and notoginseng in cancer chemoprevention.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aggarwal, B. B., Van Kuiken, M. E., Iyer, L. H., et al. (2009). Molecular targets of nutraceuticals derived from dietary spices: Potential role in suppression of inflammation and tumorigenesis. Experimental Biology and Medicine (Maywood), 234, 825–849.
Akerele, O. (1993). Nature’s medicinal bounty: Don’t throw it away. World Health Forum, 14, 390–395.
Assinewe, V. A., Baum, B. R., Gagnon, D., et al. (2003). Phytochemistry of wild populations of Panax quinquefolius L. (North American ginseng). Journal of Agricultural and Food Chemistry, 51, 4549–4553.
Attele, A. S., Wu, J. A., & Yuan, C. S. (1999). Ginseng pharmacology: Multiple constituents and multiple actions. Biochemical Pharmacology, 58, 1685–1693.
Aung, H. H., Mehendale, S. R., Wang, C. Z., et al. (2007). Cisplatin’s tumoricidal effect on human breast carcinoma MCF-7 cells was not attenuated by American ginseng. Cancer Chemotherapy and Pharmacology, 59, 369–374.
Barnes, P. M., Powell-Griner, E., McFann, K., et al. (2004). Complementary and alternative medicine use among adults: United States, 2002. Advance Data, 22, 1–19.
Barton, D. L., Soori, G. S., Bauer, B. A., et al. (2010). Pilot study of Panax quinquefolius (American ginseng) to improve cancer-related fatigue: A randomized, double-blind, dose-finding evaluation: NCCTG trial N03CA. Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer, 18, 179–187.
Benjamin, M., Kaiser, E., & Milz, S. (2008). Structure-function relationships in tendons: A review. Journal of Anatomy, 212, 211–228.
Chao, Z., Shoyama, Y., & Tanaka, H. (2006). Pharmacokinetic study of ginsenosides Rb1 and Rg1 in rat by ELISA using anti-ginsenosides Rb1 and Rg1 monoclonal antibodies. The American Journal of Chinese Medicine, 34, 1069–1081.
Chen, F. D., Wu, M. C., Wang, H. E., et al. (2001). Sensitization of a tumor, but not normal tissue, to the cytotoxic effect of ionizing radiation using Panax notoginseng extract. The American Journal of Chinese Medicine, 29, 517–524.
Chen, Y., Zhan, E., Chen, H., et al. (2002). Saponins with low sugar chain from the leaves of Panax notoginseng (Burk) F. H. Chen. Zhong Yao Cai Zhongyaocai (Journal of Chinese Medicinal Materials), 25, 176–178.
Corbit, R., Ebbs, S., King, M. L., et al. (2006). The influence of lead and arsenite on the inhibition of human breast cancer MCF-7 cell proliferation by American ginseng root (Panax quinquefolius L.). Life Sciences, 78, 1336–1340.
Fuzzati, N. (2004). Analysis methods of ginsenosides. Journal of Chromatography. B: Analytical Technologies in the Biomedical and Life Sciences, 812, 119–133.
Goldberg, R. M., Sargent, D. J., Morton, R. F., et al. (2004). A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 22, 23–30.
Helms, S. (2004). Cancer prevention and therapeutics: Panax ginseng. Alternative Medicine Review: A Journal of Clinical Therapeutic, 9, 259–274.
Hofseth, L. J., & Wargovich, M. J. (2007). Inflammation, cancer, and targets of ginseng. The Journal of Nutrition, 137, 183S–185S.
Hurwitz, H., Fehrenbacher, L., Novotny, W., et al. (2004). Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. The New England Journal of Medicine, 350, 2335–2342.
Iishi, H., Tatsuta, M., Baba, M., et al. (1997). Inhibition by ginsenoside Rg3 of bombesin-enhanced peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane in Wistar rats. Clinical & Experimental Metastasis, 15, 603–611.
Jemal, A., Siegel, R., Xu, J., et al. (2010) Cancer statistics, 2010. CA: A Cancer Journal For Clinicians, 60, 277–300.
Jeong, A., Lee, H. J., Jeong, S. J., et al. (2010). Compound K inhibits basic fibroblast growth factor-induced angiogenesis via regulation of p38 mitogen activated protein kinase and AKT in human umbilical vein endothelial cells. Biological & Pharmaceutical Bulletin, 33, 945–950.
Jia, W. W., Bu, X., Philips, D., et al. (2004). Rh2, a compound extracted from ginseng, hypersensitizes multidrug-resistant tumor cells to chemotherapy. Canadian Journal of Physiology and Pharmacology, 82, 431–437.
Jin, Y., Hofseth, A. B., Cui, X., et al. (2010). American ginseng suppresses colitis through p53-mediated apoptosis of inflammatory cells. Cancer Prevention Research (Philadelphia, Pa.), 3, 339–347.
Kim, S. H., & Park, K. S. (2003). Effects of Panax ginseng extract on lipid metabolism in humans. Pharmacological Research: The Official Journal of the Italian Pharmacological Society, 48, 511–513.
Kim, H. S., Lee, E. H., Ko, S. R., et al. (2004). Effects of ginsenosides Rg3 and Rh2 on the proliferation of prostate cancer cells. Archives of Pharmacal Research, 27, 429–435.
Kim, S. J., Jeong, H. J., Yi, B. J., et al. (2007). Transgenic Panax ginseng inhibits the production of TNF-alpha, IL-6, and IL-8 as well as COX-2 expression in human mast cells. The American Journal of Chinese medicine, 35, 329–339.
Kim, S. M., Lee, S. Y., Cho, J. S., et al. (2010). Combination of ginsenoside Rg3 with docetaxel enhances the susceptibility of prostate cancer cells via inhibition of NF-kappaB. European Journal of Pharmacology, 631, 1–9.
Kimura, Y., Sumiyoshi, M., Kawahira, K., et al. (2006). Effects of ginseng saponins isolated from red ginseng roots on burn wound healing in mice. British Journal of Pharmacology, 148, 860–870.
Kitts, D. D., Wijewickreme, A. N., & Hu, C. (2000). Antioxidant properties of a North American ginseng extract. Molecular and Cellular Biochemistry, 203, 1–10.
Koo, H. N., Jeong, H. J., Choi, I. Y., et al. (2007). Mountain grown ginseng induces apoptosis in HL-60 cells and its mechanism have little relation with TNF-alpha production. The American Journal of Chinese Medicine, 35, 169–182.
Lau, A. J., Seo, B. H., Woo, S. O., et al. (2004). High-performance liquid chromatographic method with quantitative comparisons of whole chromatograms of raw and steamed Panax notoginseng. Journal of Chromatography, 1057, 141–149.
Lee, K. D., & Huemer, R. P. (1971). Antitumoral activity of Panax ginseng extracts. Japanese Journal of Pharmacology, 21, 299–302.
Lee, J. Y., Shin, J. W., Chun, K. S., et al. (2005). Antitumor promotional effects of a novel intestinal bacterial metabolite (IH-901) derived from the protopanaxadiol-type ginsenosides in mouse skin. Carcinogenesis, 26, 359–367.
Lee, T. I., Chen, H. H., & Yeh, M. L. (2006). Effects of chan-chuang qigong on improving symptom and psychological distress in chemotherapy patients. The American Journal of Chinese Medicine, 34, 37–46.
Leung, P. C. (2007). The efficacy of Chinese medicine for SARS: A review of Chinese publications after the crisis. The American Journal of Chinese Medicine, 35, 575–581.
Li, X. J., & Zhang, H. Y. (2008). Western-medicine-validated anti-tumor agents and traditional Chinese medicine. Trends in Molecular Medicine, 14, 1–2.
Li, B., Wang, C. Z., He, T. C., et al. (2010). Antioxidants potentiate American ginseng induced killing of colorectal cancer cells. Cancer Letters, 289, 62–70.
Liu, X. S., & Jiang, J. (2006). Molecular mechanism of matrine-induced apoptosis in leukemia K562 cells. The American Journal of Chinese Medicine, 34, 1095–1103.
Liu, R., Xing, D., Lu, H., et al. (2006). Pharmacokinetics of puerarin and ginsenoside Rg1 of CBN injection and the relation with platelet aggregation in rats. The American Journal of Chinese Medicine, 34, 1037–1045.
Lu, P., Su, W., Miao, Z. H., et al. (2008). Effect and mechanism of ginsenoside Rg3 on postoperative life span of patients with non-small cell lung cancer. Chinese Journal of Integrative Medicine, 14(1), 33–36.
Luo, X., Wang, C. Z., Chen, J., et al. (2008). Characterization of gene expression regulated by American ginseng and ginsenoside Rg3 in human colorectal cancer cells. International Journal of Oncology, 32, 975–983.
Ma, W. W., & Adjei, A. A. (2009). Novel agents on the horizon for cancer therapy. CA: A Cancer Journal for Clinicians, 59, 111–137.
Mashour, N. H., Lin, G. I., & Frishman, W. H. (1998). Herbal medicine for the treatment of cardiovascular disease: Clinical considerations. Archives of Internal Medicine, 158, 2225–2234.
Mehendale, S., Aung, H., Wang, A., et al. (2005). American ginseng berry extract and ginsenoside Re attenuate cisplatin-induced kaolin intake in rats. Cancer Chemotherapy and Pharmacology, 56, 63–69.
Mochizuki, M., Yoo, Y. C., Matsuzawa, K., et al. (1995). Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside-Rb2, 20(R)- and 20(S)-ginsenoside-Rg3, of red ginseng. Biological & Pharmaceutical Bulletin, 18, 1197–1202.
Ng, T. B. (2006). Pharmacological activity of sanchi ginseng (Panax notoginseng). The Journal of Pharmacy and Pharmacology, 58, 1007–1019.
Ng, L. T., Chiang, L. C, Lin, Y. T., et al. (2006). Antiproliferative and apoptotic effects of tetrandrine on different human hepatoma cell lines. The American Journal of Chinese Medicine, 34, 125–135.
Ooi, L. S., Li, Y., Kam, S. L., et al. (2006). Antimicrobial activities of cinnamon oil and cinnamaldehyde from the Chinese medicinal herb Cinnamomum cassia blume. The American Journal of Chinese Medicine, 34, 511–522.
Ott, M. J. (2002). Complementary and alternative therapies in cancer symptom management. Cancer Practice, 10, 162–166.
Ozaslan, M., Didem Karagoz, I., Kalender, M. E., et al. (2007). In vivo antitumoral effect of Plantago major L. extract on Balb/C mouse with Ehrlich ascites tumor. The American Journal of Chinese Medicine, 35, 841–851.
Popovich, D. G., & Kitts, D. D. (2002). Structure-function relationship exists for ginsenosides in reducing cell proliferation and inducing apoptosis in the human leukemia (THP-1) cell line. Archives of Biochemistry and Biophysics, 406, 1–8.
Qi, L. W., Wang, C. Z., & Yuan, C. S. (2010). American ginseng: Potential structure-function relationship in cancer chemoprevention. Biochemical Pharmacology, 80, 947–954.
Ren, H. C., Sun, J. G., Wang, G. J., et al. (2008). Sensitive determination of 20(S)-protopanaxadiol in rat plasma using HPLC-APCI-MS: Application of pharmacokinetic study in rats. Journal of Pharmaceutical and Biomedical Analysis, 48, 1476–1480.
Shieh, D. E., Cheng, H. Y., Yen, M. H., et al. (2006). Baicalin-induced apoptosis is mediated by Bcl-2-dependent, but not p53-dependent, pathway in human leukemia cell lines. The American Journal of Chinese Medicine, 34, 245–261.
Shumay, D. M., Maskarinec, G., Kakai, H., et al. (2001). Why some cancer patients choose complementary and alternative medicine instead of conventional treatment. The Journal of Family Practice, 50, 1067.
Sun, H., Ye, Y., & Pan, Y. (2005). Immunological-adjuvant saponins from the roots of Panax notoginseng. Chemistry & Biodiversity, 2, 510–515.
Sun, S., Wang, C. Z., Tong, R., et al. (2010). Effects of steaming the root of Panax notoginseng on chemical composition and anticancer activities. Food Chemistry, 118, 307–314.
Wakabayashi, C., Hasegawa, H., Murata, J., et al. (1997). In vivo antimetastatic action of ginseng protopanaxadiol saponins is based on their intestinal bacterial metabolites after oral administration. Oncology Research, 9, 411–417.
Wang, C. Z., McEntee, E., Wicks, S., et al. (2006a). Phytochemical and analytical studies of Panax notoginseng (Burk.) F.H. Chen. Journal of Natural Medicines, 60, 97–106.
Wang, C. Z., Wu, J. A., McEntee, E., et al. (2006b). Saponins composition in American ginseng leaf and berry assayed by high-performance liquid chromatography. Journal of Agricultural and Food Chemistry, 54, 2261–2266.
Wang, C. Z., Zhang, B., Song, W. X., et al. (2006c). Steamed American ginseng berry: Ginsenoside analyses and anticancer activities. Journal of Agricultural and Food Chemistry, 54, 9936–9942.
Wang, C. Z., Aung, H. H., Ni, M., et al. (2007a). Red American ginseng: Ginsenoside constituents and antiproliferative activities of heat-processed Panax quinquefolius roots. Planta Medica, 73, 669–674.
Wang, C. Z., Luo, X., Zhang, B., et al. (2007b). Notoginseng enhances anti-cancer effect of 5-fluorouracil on human colorectal cancer cells. Cancer Chemotherapy and Pharmacology, 60, 69–79.
Wang, C. Z., Mehendale, S. R., & Yuan, C. S. (2007c). Commonly used antioxidant botanicals: Active constituents and their potential role in cardiovascular illness. The American Journal of Chinese Medicine, 35, 543–558.
Wang, W., Zhao, Y., Rayburn, E. R., et al. (2007d). In vitro anti-cancer activity and structure-activity relationships of natural products isolated from fruits of Panax ginseng. Cancer Chemotherapy and Pharmacology, 59, 589–601.
Wang, C. Z., Aung, H. H., Zhang, B., et al. (2008). Chemopreventive effects of heat-processed Panax quinquefolius root on human breast cancer cells. Anticancer Research, 28, 2545–2551.
Wang, C. Z., Li, X. L., Wang, Q. F., et al. (2009a). The mitochondrial pathway is involved in American ginseng-induced apoptosis of SW-480 colon cancer cells. Oncology Reports, 21, 577–584.
Wang, C. Z., Xie, J. T., Fishbein, A., et al. (2009b). Antiproliferative effects of different plant parts of Panax notoginseng on SW480 human colorectal cancer cells. Phytotherapy Research: PTR, 23, 6–13.
Wang, X., Sakuma, T., Asafu-Adjaye, E., et al. (1999). Determination of ginsenosides in plant extracts from Panax ginseng and Panax quinquefolius L. by LC/MS/MS. Analytical Chemistry, 71, 1579–1584.
White, C. M., Fan, C., Song, J., et al. (2001). An evaluation of the hemostatic effects of hydrophilic, alcohol, and lipophilic extracts of notoginseng. Pharmacotherapy, 21, 773–777.
Wicks, S. M., Tong, R., Wang, C. Z., et al. (2007). Safety and tolerability of Ganoderma lucidum in healthy subjects: A double-blind randomized placebo-controlled trial. The American Journal of Chinese Medicine, 35, 407–414.
Wu, H., Yang, F., Cui, S., et al. (2007). Hematopoietic effect of fractions from the enzyme-digested colla corii asini on mice with 5-fluorouracil induced anemia. The American Journal of Chinese Medicine, 35, 853–866.
Xie, J. T., Chang, W. T., Wang, C. Z., et al. (2006). Curry leaf (Murraya koenigii Spreng.) reduces blood cholesterol and glucose levels in ob/ob mice. The American Journal of Chinese Medicine, 34, 279–284.
Xu, S. X., Chen, Y. J., Cai, Z. Q., et al. (1987). Studies on the chemical constituents of Panax quinquefolius Linn. Yao Xue Xue Bao, 22, 750–755.
Yamakage, M., Hattori, J., Satoh, J., et al. (2006). Effects of the Chinese herbal medicines Bupleuri radix, Ginseng radix, and Zingiberis rhizoma on lymphatic vessel activity in rats. The American Journal of Chinese Medicine, 34, 1063–1068.
Yoo, H. H., Yokozawa, T., Satoh, A., et al. (2006). Effects of ginseng on the proliferation of human lung fibroblasts. The American Journal of Chinese Medicine, 34, 137–146.
Yuan, C. S., & Dey, L. (2001). Multiple effects of American ginseng in clinical medicine. The American Journal of Chinese Medicine, 29, 567–569.
Yun, T. K. (2003). Experimental and epidemiological evidence on non-organ specific cancer preventive effect of Korean ginseng and identification of active compounds. Mutation Research, 523/524, 63–74.
Yun, T. K., & Choi, S. Y. (1995). Preventive effect of ginseng intake against various human cancers: A case-control study on 1987 pairs. Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 4, 401–408.
Yun, T. K., & Choi, S. Y. (1998). Non-organ specific cancer prevention of ginseng: A prospective study in Korea. International Journal of Epidemiology, 27, 359–364.
Yun, T. K., Lee, Y. S., Lee, Y. H., et al. (2001). Anticarcinogenic effect of Panax ginseng C.A. Meyer and identification of active compounds. Journal of Korean Medical Science, 16(Suppl), S6–S18.
Zhou, X., Lin, J., Yin, Y., et al. (2007). Ganodermataceae: Natural products and their related pharmacological functions. The American Journal of Chinese Medicine, 35, 559–574.
Acknowledgments
This work was supported in part by the NIH/NCCAM grants AT004418 and AT005362.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Wang, CZ., Yuan, CS. (2011). Panax Quinquefolius (American Ginseng) and Panax Notoginseng (Notoginseng) in Cancer Chemoprevention. In: Cho, W. (eds) Evidence-based Anticancer Materia Medica. Evidence-based Anticancer Complementary and Alternative Medicine. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-0526-5_5
Download citation
DOI: https://doi.org/10.1007/978-94-007-0526-5_5
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-0525-8
Online ISBN: 978-94-007-0526-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)